JPH0257071B2 - - Google Patents

Info

Publication number
JPH0257071B2
JPH0257071B2 JP59076834A JP7683484A JPH0257071B2 JP H0257071 B2 JPH0257071 B2 JP H0257071B2 JP 59076834 A JP59076834 A JP 59076834A JP 7683484 A JP7683484 A JP 7683484A JP H0257071 B2 JPH0257071 B2 JP H0257071B2
Authority
JP
Japan
Prior art keywords
compound
reaction
alkyl group
acid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59076834A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60218394A (ja
Inventor
Tatsuo Nishimura
Yoshinobu Yoshimura
Mitsuo Numata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP59076834A priority Critical patent/JPS60218394A/ja
Priority to NZ208281A priority patent/NZ208281A/en
Priority to AU28748/84A priority patent/AU566096B2/en
Priority to CA000455318A priority patent/CA1216285A/fr
Priority to IN371/CAL/84A priority patent/IN158586B/en
Priority to AR296794A priority patent/AR240825A1/es
Priority to HU842135A priority patent/HU192028B/hu
Priority to GR74891A priority patent/GR79941B/el
Priority to DE8484303704T priority patent/DE3476662D1/de
Priority to NO842224A priority patent/NO162470C/no
Priority to FI842210A priority patent/FI75574C/fi
Priority to AT84303704T priority patent/ATE40691T1/de
Priority to EP84303704A priority patent/EP0128029B1/fr
Priority to ES533051A priority patent/ES8506577A1/es
Priority to PH30757A priority patent/PH19575A/en
Priority to DK273784A priority patent/DK273784A/da
Priority to KR1019840003078A priority patent/KR910008350B1/ko
Priority to PT78684A priority patent/PT78684B/pt
Priority to ES540839A priority patent/ES8607317A1/es
Publication of JPS60218394A publication Critical patent/JPS60218394A/ja
Priority to ES549761A priority patent/ES8703480A1/es
Priority to ES556838A priority patent/ES8801287A1/es
Priority to US07/027,433 priority patent/US5120841A/en
Priority to AR87308151A priority patent/AR245132A1/es
Priority to MYPI87001501A priority patent/MY101993A/en
Publication of JPH0257071B2 publication Critical patent/JPH0257071B2/ja
Priority to SG3/92A priority patent/SG392G/en
Priority to HK94/92A priority patent/HK9492A/xx
Priority to BG098471A priority patent/BG60500B2/bg
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59076834A 1983-06-02 1984-04-16 セフアロスポリンエステル誘導体 Granted JPS60218394A (ja)

Priority Applications (27)

Application Number Priority Date Filing Date Title
JP59076834A JPS60218394A (ja) 1984-04-16 1984-04-16 セフアロスポリンエステル誘導体
NZ208281A NZ208281A (en) 1983-06-02 1984-05-25 Cephalosporin ester derivatives and pharmaceutical compositions
AU28748/84A AU566096B2 (en) 1983-06-02 1984-05-28 Cephalosporin ester derivatives
CA000455318A CA1216285A (fr) 1983-06-02 1984-05-29 Derives d'ester de cephalosporine, production et utilisation
IN371/CAL/84A IN158586B (fr) 1983-06-02 1984-05-29
AR296794A AR240825A1 (es) 1983-06-02 1984-05-30 Procedimiento para obtener compuestos de 7-(2-aminotiazol-4-il-acetamido-3(((1-(2-dimetil aminoetil)-1h-tetrazol-5-il)tio)metil)-cef-3-em-4-carboxilato y sus sales
HU842135A HU192028B (en) 1983-06-02 1984-05-31 Process for production of derivates of cefem esthers of carbonic acid
GR74891A GR79941B (fr) 1983-06-02 1984-05-31
EP84303704A EP0128029B1 (fr) 1983-06-02 1984-06-01 Dérivés de céphalosporine, leur préparation et leur application
DK273784A DK273784A (da) 1983-06-02 1984-06-01 Cephalosporinesterderivater, deres fremstilling og anvendelse
NO842224A NO162470C (no) 1983-06-02 1984-06-01 Analogifremgangsmaate for fremstilling av terapeutisk aktiv ester av 7beta-(2-(2-amino-tiazol-4-yl)acetamido)-3-(((1-(2-dimetylamino-etyl)-1h-tetrazol-5-yl)tio)metyl)-cef-3-em-4-karboksylsyre.
FI842210A FI75574C (fi) 1983-06-02 1984-06-01 Foerfarande foer framstaellning av en terapeutiskt anvaendbar 7 -/2-(2-aminotiazol)-4-yl)acetamido/-3-///1- (2-dimetylaminoetyl)-1h-tetrazol-5-yl/tio/metyl/cef-3-em-4- karboxylsyraester.
AT84303704T ATE40691T1 (de) 1983-06-02 1984-06-01 Cephalosporinderivate, ihre herstellung und ihre verwendung.
DE8484303704T DE3476662D1 (en) 1983-06-02 1984-06-01 Cephalosporin ester derivatives, their production and use
ES533051A ES8506577A1 (es) 1983-06-02 1984-06-01 Procedimiento para preparar un derivado de ester de cefalosporina
PH30757A PH19575A (en) 1983-06-02 1984-06-01 Cephalosporing derivatives and pharmaceutical compositions thereof
KR1019840003078A KR910008350B1 (ko) 1983-06-02 1984-06-02 세팔로스포린 에스테르 유도체의 제조방법
PT78684A PT78684B (en) 1983-06-02 1984-06-06 Cephalosporin ester derivatives their production and use
ES540839A ES8607317A1 (es) 1983-06-02 1985-03-01 Un procedimiento para producir un derivado de ester de cefa-losporina
ES549761A ES8703480A1 (es) 1983-06-02 1985-12-10 Un procedimiento para producir un derivado de ester de cefe-losporina
ES556838A ES8801287A1 (es) 1983-06-02 1986-06-30 Un procedimiento para producir derivados de ester de cefalosporina.
US07/027,433 US5120841A (en) 1983-06-02 1987-03-18 Cephalosporin ester derivatives
AR87308151A AR245132A1 (es) 1983-06-02 1987-07-15 Un procedimiento para la produccion de compuestos de 7-(2-aminotiazol-4-il) acetamido-3-(((1-(2-dimetilaminoetil-1h-tetrazol-5-il)tio )metil)-cef-3-em-4-carboxilico
MYPI87001501A MY101993A (en) 1983-06-02 1987-09-01 Cephalosporin ester derivatives their production and use.
SG3/92A SG392G (en) 1983-06-02 1992-01-02 Cephalosporin ester derivatives,their production and use
HK94/92A HK9492A (en) 1983-06-02 1992-01-30 Cephalosporin ester derivatives,their production and use
BG098471A BG60500B2 (bg) 1983-06-02 1994-02-14 Естери на цефалоспорина

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59076834A JPS60218394A (ja) 1984-04-16 1984-04-16 セフアロスポリンエステル誘導体

Publications (2)

Publication Number Publication Date
JPS60218394A JPS60218394A (ja) 1985-11-01
JPH0257071B2 true JPH0257071B2 (fr) 1990-12-03

Family

ID=13616703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59076834A Granted JPS60218394A (ja) 1983-06-02 1984-04-16 セフアロスポリンエステル誘導体

Country Status (1)

Country Link
JP (1) JPS60218394A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49290A (fr) * 1972-03-13 1974-01-05
JPS5512913A (en) * 1978-07-14 1980-01-29 Ricoh Co Ltd Light-and heat-sensitive copying material
JPS5849387A (ja) * 1981-09-17 1983-03-23 Sankyo Co Ltd 7−メトキシセフアロスポリン化合物およびその製法
JPS58167594A (ja) * 1982-03-26 1983-10-03 Sankyo Co Ltd 経口用セフアロスポリン化合物
JPS59225192A (ja) * 1983-06-02 1984-12-18 Takeda Chem Ind Ltd セフアロスポリンエステル誘導体

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49290A (fr) * 1972-03-13 1974-01-05
JPS5512913A (en) * 1978-07-14 1980-01-29 Ricoh Co Ltd Light-and heat-sensitive copying material
JPS5849387A (ja) * 1981-09-17 1983-03-23 Sankyo Co Ltd 7−メトキシセフアロスポリン化合物およびその製法
JPS58167594A (ja) * 1982-03-26 1983-10-03 Sankyo Co Ltd 経口用セフアロスポリン化合物
JPS59225192A (ja) * 1983-06-02 1984-12-18 Takeda Chem Ind Ltd セフアロスポリンエステル誘導体

Also Published As

Publication number Publication date
JPS60218394A (ja) 1985-11-01

Similar Documents

Publication Publication Date Title
JP3467418B2 (ja) ホスフォノセフェム誘導体、その製造法および用途
JP2509689B2 (ja) セファロスポリン誘導体およびそれらの製法
JP2867192B2 (ja) 7−アシル−3−置換カルバモイルオキシセフェム化合物及びその製造法
US5120841A (en) Cephalosporin ester derivatives
KR0173796B1 (ko) 세팔로스포린 화합물 및 그의 제조방법
JPH0257071B2 (fr)
JPH021835B2 (fr)
US4725592A (en) 1-Acyloxyalkyl esters of cephalosporin
US4755598A (en) 1'-(substituted)ethyl-7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylate derivatives having antibacterial utility
CA1215354A (fr) Esters de cephalosporine, leur production et leur emploi
JPS609698B2 (ja) 経口投与用セフアロスポリン剤
JPH093074A (ja) セファロスポリン化合物、その用途および中間体化合物
GB2051066A (en) Cephalosporin derivatives suitable for oral administration
JPS59225192A (ja) セフアロスポリンエステル誘導体
US4729992A (en) Cephalosporin esters, their production and use
JPH0526794B2 (fr)
JPH0454675B2 (fr)
JPS60239490A (ja) セフアロスポリン誘導体
JPH05306288A (ja) セフェムエステル化合物の結晶
JPS58135894A (ja) 7―置換ブチルアミド―3―ビニルセファロスポラン酸誘導体
JPH051074A (ja) セフエム化合物
JPH0481579B2 (fr)
JPS6067482A (ja) セフアロスポリンエステル
JPH0240073B2 (ja) Shinkisefuarosuhorinkagobutsuoyobisoreojukoseibuntosurukokinzai
JPH01203393A (ja) 新規セフアロスポリン系化合物

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term